Video

SK Pharmteco Capabilities Update March 2026: Small Molecule Drug Substance

Source: SK pharmteco

SK pharmteco is a leading global CDMO delivering advanced technologies and integrated solutions across small molecule APIs, peptides, and antibody–drug conjugate (ADC) payloads and linkers. Backed by decades of experience and a strong track record of quality, regulatory compliance, and reliability, we partner with clients to keep development programs on track and positioned for success.

Join Frank Mueller, Executive Director of Business Development, for an overview of our capabilities and global capacity spanning North America, Europe, and Asia. From early clinical development through full-scale commercial manufacturing, discover how SK pharmteco combines technical expertise, flexible infrastructure, and a customer-focused approach to deliver complex programs with confidence.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

SK pharmteco